CD8A and AIDS: In summary, the results of this large prospective cohort support the use of a CD4/CD8 ratio cut-off of <0.3, regardless of CD4 count, to identify PWH with an excess risk of cardiovascular events, non-AIDS-defining malignancies, and all-cause mortality.